Background:
Because transfecting a large number of plasmids (~8) into HEK293 cells can drastically increase cytotoxicity and lower transfection efficiency, we are optimizing our transfections before we start characterizing the B-Cell Receptor. We plan on evaluating suspended vs. adherent transfection and varying total mass of DNA transfected. Because we will be transfecting a large protein complex (BCR) into our cells we want to use many different plasmids interacting to test our transfection efficiency.
Parts Needed:
hEF1a:rtTA
TRE:Gal4VP16
UAS:mKate
hEF1a:eYFP
hEF1a:eBFP
Procedure:
We will be testing in duplicate 10, 25, 50,100, 250, 500, and 1000ng of DNA with lipo 3K suspended vs non suspended transfection to determine optimal transfection conditions for our cells.
The plate map is as follows. Using lipo3k protocol.
HEK293 Plain | 2ng hEF1a:rtTA 2ng TRE:Gal4VP16 2ng UAS:mKate 2ng hEF1a:eYFP 2ng hEF1a:eBFP | 5ng hEF1a:rtTA 5ng TRE:Gal4VP16 5ng UAS:mKate 5ng hEF1a:eYFP 5ng hEF1a:eBFP | 10ng hEF1a:rtTA 10ng TRE:Gal4VP16 10ng UAS:mKate 10ng hEF1a:eYFP 10ng hEF1a:eBFP | 20ng hEF1a:rtTA 20ng TRE:Gal4VP16 20ng UAS:mKate 20ng hEF1a:eYFP 20ng hEF1a:eBFP | 50ng hEF1a:rtTA 50ng TRE:Gal4VP16 50ng UAS:mKate 50ng hEF1a:eYFP 50ng hEF1a:eBFP |
100ng hEF1a:rtTA 100ng TRE:Gal4VP16 100ng UAS:mKate 100ng hEF1a:eYFP 100ng hEF1a:eBFP | 200ng hEF1a:rtTA 200ng TRE:Gal4VP16 200ng UAS:mKate 200ng hEF1a:eYFP 200ng hEF1a:eBFP | ||||
HEK293 Plain | 2ng hEF1a:rtTA 2ng TRE:Gal4VP16 2ng UAS:mKate 2ng hEF1a:eYFP 2ng hEF1a:eBFP | 5ng hEF1a:rtTA 5ng TRE:Gal4VP16 5ng UAS:mKate 5ng hEF1a:eYFP 5ng hEF1a:eBFP | 10ng hEF1a:rtTA 10ng TRE:Gal4VP16 10ng UAS:mKate 10ng hEF1a:eYFP 10ng hEF1a:eBFP | 20ng hEF1a:rtTA 20ng TRE:Gal4VP16 20ng UAS:mKate 20ng hEF1a:eYFP 20ng hEF1a:eBFP | 50ng hEF1a:rtTA 50ng TRE:Gal4VP16 50ng UAS:mKate 50ng hEF1a:eYFP 50ng hEF1a:eBFP |
100ng hEF1a:rtTA 100ng TRE:Gal4VP16 100ng UAS:mKate 100ng hEF1a:eYFP 100ng hEF1a:eBFP | 200ng hEF1a:rtTA 200ng TRE:Gal4VP16 200ng UAS:mKate 200ng hEF1a:eYFP 200ng hEF1a:eBFP |
Results: